Table 3. Associations between seropositivity of human papillomavirus (HPV) types 16 or 18 and selected history of cancer outcomes.
| Cancer | Adjusted odds ratioa | 95% confidence interval | Sexb | |
|---|---|---|---|---|
| Lifetime | 1.68 | 1.35 | 2.09 | F+M |
| 1.81 | 0.98 | 3.33 | M | |
| 1.57 | 1.22 | 2.01 | F | |
| Eight selected | 2.63 | 1.78 | 3.90 | F+M |
| 2.57 | 0.67 | 9.83 | M | |
| 2.57 | 1.64 | 4.03 | F | |
| Cervix | 2.55 | 1.63 | 3.98 | F |
| Lung | 5.14 | 1.29 | 20.44 | F+M |
| 5.04 | 1.34 | 18.92 | F | |
a
Models were adjusted for sex, age, education, race, poverty income ratio (PIR), body mass index (BMI), smoking status, and alcohol-use status. Sampling weights were applied to account for the complex sampling National Health and Nutrition Examination Survey (NHANES) design.
b
Models were run on the whole population with both females and males (F+M), and for male-(M) or female-(F) only data sets.